NEW YORK (GenomeWeb) — Nanosphere said today that it has been selected by HealthTrust to provide multi-target molecular diagnostic tests for nearly 1,400 acute care facilities that are part of the HealthTrust membership.

Under the agreement, HealthTrust's members will have access to purchase Nanosphere's portfolio of Verigene multiplex molecular diagnostics tests for infectious diseases, including assays for detecting infections of the bloodstream, respiratory tract, and gastrointestinal tract.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.